Assessing the impact of adaptations to the clinical workflow in radiotherapy using transit in vivo dosimetry
- PMID: 36820237
- PMCID: PMC9937948
- DOI: 10.1016/j.phro.2023.100420
Assessing the impact of adaptations to the clinical workflow in radiotherapy using transit in vivo dosimetry
Abstract
Background and purpose: Currently in-vivo dosimetry (IVD) is primarily used to identify individual patient errors in radiotherapy. This study investigated possible correlations of observed trends in transit IVD results, with adaptations to the clinical workflow, aiming to demonstrate the possibility of using the bulk data for continuous quality improvement.
Materials and methods: In total 84,100 transit IVD measurements were analyzed of all patients treated between 2018 and 2022, divided into four yearly periods. Failed measurements (FM) were divided per pathology and into four categories of causes of failure: technical, planning and positioning problems, and anatomic changes.
Results: The number of FM due to patient related problems gradually decreased from 9.5% to 6.6%, 6.1% and 5.6% over the study period. FM attributed to positioning problems decreased from 10.0% to 4.9% in boost breast cancer patients after introduction of extra imaging, from 9.1% to 3.9% in Head&Neck patients following education of radiation therapists on positioning of patients' shoulders, from 6.1% to 2.8% in breast cancer patients after introduction of ultrahypofractionated breast radiotherapy with daily online pre-treatment imaging and from 11.2% to 4.3% in extremities following introduction of immobilization with calculated couch parameters and a Surface Guided Radiation Therapy solution. FM related to anatomic changes decreased from 10.2% to 4.0% in rectum patients and from 6.7% to 3.3% in prostate patients following more patient education from dieticians.
Conclusions: Our study suggests that IVD can be a powerful tool to assess the impact of adaptations to the clinical workflow and its use for continuous quality improvement.
Keywords: Continuous quality improvement; EPID, Electronic Portal Imaging Device; FM, Failed Measurements; H&N, Head&Neck; HU, Hounsfield Units; IVD, In-vivo Dosimetry; In vivo; PSQA, Patient Specific Quality Assurance; Perfraction; Transit dosimetry; VMAT, Volumetric Modulated Arc Therapy.
© 2023 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
EPID-based in vivo dosimetry using Dosimetry Check™: Overview and clinical experience in a 5-yr study including breast, lung, prostate, and head and neck cancer patients.J Appl Clin Med Phys. 2019 Jan;20(1):6-16. doi: 10.1002/acm2.12441. Epub 2018 Dec 7. J Appl Clin Med Phys. 2019. PMID: 30536528 Free PMC article.
-
Improving dose delivery accuracy with EPID in vivo dosimetry: results from a multicenter study.Strahlenther Onkol. 2021 Jul;197(7):633-643. doi: 10.1007/s00066-021-01749-6. Epub 2021 Feb 16. Strahlenther Onkol. 2021. PMID: 33594471
-
Evaluation of automated pre-treatment and transit in-vivo dosimetry in radiotherapy using empirically determined parameters.Phys Imaging Radiat Oncol. 2020 Nov 9;16:113-129. doi: 10.1016/j.phro.2020.09.011. eCollection 2020 Oct. Phys Imaging Radiat Oncol. 2020. PMID: 33458354 Free PMC article.
-
In vivo dosimetry in external beam radiotherapy.Med Phys. 2013 Jul;40(7):070903. doi: 10.1118/1.4811216. Med Phys. 2013. PMID: 23822404 Review.
-
A literature review of electronic portal imaging for radiotherapy dosimetry.Radiother Oncol. 2008 Sep;88(3):289-309. doi: 10.1016/j.radonc.2008.07.008. Epub 2008 Aug 14. Radiother Oncol. 2008. PMID: 18706727 Review.
Cited by
-
Machine learning and lean six sigma for targeted patient-specific quality assurance of volumetric modulated arc therapy plans.Phys Imaging Radiat Oncol. 2024 Aug 9;31:100617. doi: 10.1016/j.phro.2024.100617. eCollection 2024 Jul. Phys Imaging Radiat Oncol. 2024. PMID: 39224688 Free PMC article.
-
A commissioning protocol for portal imaging-based radiotherapy in vivo dosimetry systems.Phys Imaging Radiat Oncol. 2024 Nov 1;32:100666. doi: 10.1016/j.phro.2024.100666. eCollection 2024 Oct. Phys Imaging Radiat Oncol. 2024. PMID: 39624392 Free PMC article.
-
Validation of an in vivo transit dosimetry algorithm using Monte Carlo simulations and ionization chamber measurements.J Appl Clin Med Phys. 2024 Feb;25(2):e14187. doi: 10.1002/acm2.14187. Epub 2023 Oct 27. J Appl Clin Med Phys. 2024. PMID: 37890864 Free PMC article.
References
-
- Ortiz López P., Cosset J.M., Dunscombe P., Holmberg O., Rosenwald J.C., Pinillos Ashton L., et al. ICRP publication 112. A report of preventing accidental exposures from new external beam radiation therapy technologies. Ann ICRP. 2009;39:1–86. https://journals.sagepub.com/doi/pdf/10.1177/ANIB_39_4 - DOI - PubMed
-
- International Atomic Energy Agency. Development of procedures for in vivo dosimetry in radiotherapy. Human Health Report No. 8, IAEA, Vienna, 2013. https://www-pub.iaea.org/MTCD/Publications/PDF/Pub1606_web.pdf.
-
- International Atomic Energy Agency. Accuracy Requirements and Uncertainties in Radiotherapy, Human Health Series No. 31, IAEA, Vienna, 2016. https://www-pub.iaea.org/MTCD/Publications/PDF/P1679_HH31_web.pdf.
LinkOut - more resources
Full Text Sources